Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 21 (RPL7P21)

Target: RPL7P21
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L7 pseudogene 21 (RPL7P21) is a processed pseudogene in the human genome, meaning it is a DNA sequence derived from the ribosomal protein L7 (RPL7) gene but is non-functional and does not encode a protein[9][5][4]. Pseudogenes such as RPL7P21 typically originate from gene duplication or retrotransposition events and lack the ability to be translated into functional proteins. Consequently, RPL7P21 has no established biological function, involvement in disease processes, or role as a drug target[9][3].

Other names: RPL7_10_623[5][4]

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 21 (RPL7P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 21 (RPL7P21).

Explore the full profile